PRENWPrenetics Global Limited Warrant
0.0103USDMkt Cap: —P/E: —5d ago
Prenetics Global Limited operates as a consumer health sciences company in the United States and Hong Kong. The company focuses on advancing human health and longevity through science-backed products under the IM8 brand.…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap—
Enterprise Value—
Revenue (TTM)154.59M $
Gross Profit48.79M $
Net Income (TTM)-37.71M $
Revenue/Share9.631 USD
Last Price0.0103 USD
Fiscal Year End—
MR Quarter—
Employees98
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B0.00
EPS (TTM)-11.04
EPS (Forward)—
52W Range
—
52W High0.0103 USD
52W Low0.0103 USD
Profitability
Gross Margin52.81%
Oper. Margin-45.13%
EBITDA Margin-35.45%
Profit Margin-40.82%
ROE-24.10%
ROA-18.30%
Growth
Revenue Growth210.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.83M $
CapEx (TTM)54.56M $
FCF Margin-23.36%
FCF Yield—
Net Debt-127.88M $
Net Debt/EBITDA2.33
Balance Sheet
Debt/Equity0.01
Current Ratio4.04
Quick Ratio3.66
Book Value/Sh5.387 USD
Cash/Share7.446 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.—
Float12.86M
Insiders—
Institutions—
Technical
SMA 50—
SMA 200—
Beta—
S&P 52W Chg21.00%
Avg Vol (30d)0
Avg Vol (10d)—
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—